vimarsana.com

Page 21 - சீட்டில் புற்றுநோய் பராமரிப்பு கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

What s new in breast cancer research? SABCS20 goes virtual

What’s new in breast cancer research? SABCS20 goes virtual Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more December 18, 2020 • By Diane Mapes / Fred Hutch News Service The 2020 San Antonio Breast Cancer Symposium, held virtually this year because of COVID-19, featured the latest research to inform the care of people with breast cancer. Getty Images stock photo The San Antonio Breast Cancer Symposium was a virtual event this pandemic year, allowing thousands of breast cancer researchers, oncologists and patient advocates from around the world to log in for four full days of science and resilience writ large.

FDA to rapidly work toward authorizing Moderna COVID-19 vaccine after panel endorsement

FDA authorizes Moderna COVID-19 vaccine for emergency use By Matthew Perrone and Lauran Neergaard Published  FDA advisory committee votes to recommend emergency use of Moderna COVID-19 vaccine A key advisory committee to the FDA on Thursday voted to recommend the approval of Moderna’s COVID-19 vaccine for emergency use, one of the final hurdles before FDA authorization. WASHINGTON - The U.S. Food and Drug Administration authorized Moderna’s coronavirus vaccine for emergency use on Friday, the second vaccine to be approved by U.S. regulators to prevent severe COVID-19 illness. FDA Commissioner Stephen M. Hahn, called the approval another crucial step in the fight against this global pandemic.

FDA plans to OK 2nd COVID-19 vaccine after panel endorsement

FDA plans to OK 2nd COVID-19 vaccine after panel endorsement By MATTHEW PERRONE and LAURAN NEERGAARDDecember 18, 2020 GMT WASHINGTON (AP) The head of the Food and Drug Administration said late Thursday that his agency will move to quickly authorize the second COVID-19 vaccine to fight the pandemic, hours after the shot won the key endorsement of a government advisory panel. FDA Commissioner Stephen Hahn said in a statement that regulators have communicated their plans to drugmaker Moderna, which co-developed the vaccine with the National Institutes of Health. The announcement came after a panel of FDA advisers, in a 20-0 vote, ruled that the benefits of the vaccine outweighed the risks for those 18 years old and up.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.